2 terminated. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
| Phase 2 | 2 | Terminated 2 |
Follow rebastinib: new trials by email Literature Review of rebastinib trials Research Report on rebastinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Rebastinib (DCC-2036) in Combination With Carboplatin in Patients With Advanced or Metastatic Solid Tumors Rebastinib, Carboplatin - Locally Advanced or Metastatic Solid Tumor | Phase 1 / Phase 2 | Terminated | Deciphera Pharmaceuticals, LLC | 70 | 2019-01-02 | 2024-12-27 |
| A Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel in Patients With Advanced or Metastatic Solid Tumors Rebastinib, Paclitaxel - Locally Advanced or Metastatic Solid Tumor | Phase 1 / Phase 2 | Terminated | Deciphera Pharmaceuticals, LLC | 177 | 2018-10-25 | 2024-12-27 |
Breast Neoplasms (2) · Neoplasm Metastasis (2) · Ovarian Neoplasms (2) · Carcinosarcoma (1) · Endometrial Neoplasms (1) · Mesothelioma (1)
Deciphera Pharmaceuticals, LLC (2)
United States (2)